Ποια είναι η τιμή για Ergomed plc (2EM)

Η τιμή για Ergomed plc (2EM) είναι $13.05

Ποια είναι η κεφαλαιοποίηση αγοράς για Ergomed plc (2EM)

Η κεφαλαιοποίηση αγοράς για Ergomed plc (2EM) είναι $695.07M

Ergomed plc (2EM) Τιμή και Κεφαλαιοποίηση Αγοράς

Ergomed plc, alongside its affiliated entities, offers a comprehensive range of clinical trial services, encompassing planning, oversight, and execution, in addition to providing essential drug safety and medical information support. The company maintains an expansive global footprint, conducting operations throughout the United Kingdom, continental Europe, the Middle East, Africa, North America, Asia, and Australia. Its business is organized into two core divisions: Clinical Research Services and Pharmacovigilance. Ergomed assists pharmaceutical, biotechnology, and generic drug manufacturers by managing clinical development programs, facilitating post-market approval strategies, and delivering robust pharmacovigilance solutions. Their expertise is concentrated in several therapeutic domains, including oncology, haematology, allergy, respiratory, and neurology/CNS, with a notable specialization in the development of orphan drugs. Furthermore, they extend support services to clinical trial sites. Established in 1997, the organization originally traded as Ergomed Clinical Research Limited before rebranding as Ergomed plc in June 2014. Its corporate headquarters are situated in Guildford, United Kingdom.

Η τιμή για 2EM	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$98,811.52 $695.07M	NVDA	$5.264T	+757,209.45%
$88,250.74 $695.07M	AAPL	$4.701T	+676,269.71%
$78,412.55 $695.07M	GOOG	$4.177T	+600,868.02%
$71,658.94 $695.07M	MSFT	$3.817T	+549,107.18%
$53,805.89 $695.07M	AMZN	$2.866T	+412,278.14%

Η τιμή για 2EM

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$98,811.52 $695.07M